Evaluation of Lapatinib and Topotecan Combination Therapy: Tissue Culture, Murine Xenograft, and Phase I Clinical Trial Data

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-0415
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer

Investigational New Drugs
OncologyPharmacology
2014English

Phase II Trial of Lapatinib and Topotecan (LapTop) in Patients With Platinum-Refractory/Resistant Ovarian and Primary Peritoneal Carcinoma

Gynecologic Oncology
GynecologyOncologyObstetrics
2011English

Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2009English

Gene Therapy for Pain: Results of a Phase I Clinical Trial

Annals of Neurology
Neurology
2011English

Evaluation of Wearable Digital Devices in a Phase I Clinical Trial

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

A Phase I and Pharmacokinetic Study of Intraperitoneal Topotecan

British Journal of Cancer
Cancer ResearchOncology
2001English

Preclinical and Phase I Clinical Studies of KW-2450, a Dual IGF-1R/IR Tyrosine Kinase Inhibitor, in Combination With Lapatinib and Letrozole

Therapeutic Advances in Medical Oncology
Oncology
2018English

Escalation Strategies for Combination Therapy Phase I Trials

Pharmaceutical Statistics
StatisticsProbabilityPharmacology
2012English

A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment With Dacomitinib and Figitumumab in Advanced Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy